MYCN Impact on High-Risk Neuroblastoma: From Diagnosis and Prognosis to Targeted Treatment

SIMPLE SUMMARY: Neuroblastoma is one of the most diffuse and the deadliest cancer in children. While many advances have been made in the last few decades to improve patients’ outcome, high-risk neuroblastoma (HR-NB) still shows a very aggressive pattern of development and poor prognosis, with only a...

Descripción completa

Detalles Bibliográficos
Autores principales: Bartolucci, Damiano, Montemurro, Luca, Raieli, Salvatore, Lampis, Silvia, Pession, Andrea, Hrelia, Patrizia, Tonelli, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496712/
https://www.ncbi.nlm.nih.gov/pubmed/36139583
http://dx.doi.org/10.3390/cancers14184421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496712/
https://www.ncbi.nlm.nih.gov/pubmed/36139583
http://dx.doi.org/10.3390/cancers14184421

Ejemplares similares